Results 41 to 50 of about 26,703 (203)

Neuromyelitis optica spectrum disorder in a patient with ankylosing spondylitis: A case report

open access: yesClinical Case Reports, 2023
Key Clinical Message Neuromyelitis optica spectrum disorder is an autoimmune disease which tends to have other coexisting autoimmune or connective tissue diseases. However, coexisting with ankylosing spondylitis is rare. Here, we report a 57‐year‐old man
Mehri Salari   +2 more
doaj   +1 more source

Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families

open access: yesFrontiers in Pediatrics, 2022
Biotinidase deficiency is an autosomal recessive, multiple carboxylase deficiency usually associated with seizures, eczema, hypotonia, visual disturbances, hearing loss, and developmental delays. Only a handful of cases of biotinidase deficiency that had
Muhammad Imran Naseer   +7 more
doaj   +1 more source

Treatment of Corticosteroid Non-responsive Relapse of Neuromyelitis Optica with Intravenous Gamma Globulin – a Case Report [PDF]

open access: yesFolia Medica, 2020
We report a case of a patient with a relapse of neuromyelitis optica. The relapse was initially treated with intravenous corticosteroids. A therapy with intravenous gamma globulin was started as there was no symptomatic improvement. The patient responded
Maria Dimitrova, Dobromir Iliev
doaj   +3 more sources

Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report

open access: yesJournal of Medical Case Reports, 2019
Background Neuromyelitis optica spectrum disorders are severe autoimmune inflammatory diseases of the central nervous system associated with the presence of immunoglobulin G antibodies against the water channel protein aquaporin-4.
Susanne Bejerot   +6 more
doaj   +1 more source

The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review [PDF]

open access: yesТерапевтический архив, 2018
This case is the first description of the successful anti-B-cell therapy with rituximab in a patient with Sjogrenʼs syndrome and neuromyelitis optica spectrum disorder in Russia.
A V Torgashina, V I Vasilyev
doaj   +1 more source

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica [PDF]

open access: yes, 1887
Background: A polyspecific, intrathecal humoral immune response against neurotropic viruses such as measles, rubella and varicella zoster virus (MRZ reaction, MRZR) is present in 80--100% of patients with multiple sclerosis (MS), but has not to date been
Bergamaschi, R.   +12 more
core   +2 more sources

Biomarkers for neuromyelitis optica: a visual analysis of emerging research trends

open access: yesNeural Regeneration Research
Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system that differs from multiple sclerosis. Over the past 20 years, the search for biomarkers for neuromyelitis optica has been ongoing.
Xiangjun Li   +6 more
doaj   +1 more source

Electrical muscle stimulation intervention in the acute phase of neuromyelitis optica: Two case reports

open access: yesSAGE Open Medical Case Reports, 2020
The aim of this study was to examine the effect of electrical muscle stimulation on muscle atrophy caused by neuromyelitis optica. Two neuromyelitis optica patients with flaccid paralysis participated.
Kana Michiue, Yuichi Nishikawa
doaj   +1 more source

Neuromyelitis Optica in a Nepalese Man

open access: yesCase Reports in Neurological Medicine, 2017
Background. Neuromyelitis optica is a severely disabling inflammatory disorder of the central nervous system of autoimmune etiology that mainly affects the optic nerves and spinal cord. Here, we present a case report detailing a patient with tingling and
Yogesh Subedi   +4 more
doaj   +1 more source

The Gut Microbiome in Neuromyelitis Optica. [PDF]

open access: yes, 2017
Neuromyelitis optica (NMO) is a rare, disabling, sometimes fatal central nervous system inflammatory demyelinating disease that is associated with antibodies ("NMO IgG") that target the water channel protein aquaporin-4 (AQP4) expressed on astrocytes ...
Baranzini, Sergio E   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy